Amarin Corp Plc (AMRN)

[couldbebetter]

tucaman, Greatly appreciate your posting the numbers.
If it is accurate that new scrips for Vascepa are down
while the numbers for generic Lovaza and Lovaza are actually up,
that is a signal that something is horribly wrong!

Once again I'll opine that GIA is not the way to go.
The sooner that Vascepa is in the hands of BP the better.
Not just for those of us who own stock, but for those poor
souls who are obviously being given the generic crap instead
of pure EPA Vascepa. The FDA could care less and is feckless.
I hope JT cares about patients that are being fed a much inferior
product. How long must this idiocy go on!?!?